Wei F - Search Results

1

Cisplatin restores TRAIL apoptotic pathway in glioblastoma-derived stem cells through up-regulation of DR5 and down-regulation of c-FLIP.

Ding L, Yuan C, Wei F, Wang G, Zhang J, Bellail AC, Zhang Z, Olson JJ, Hao C. Ding L, et al. Among authors: wei f. Cancer Invest. 2011 Oct;29(8):511-20. doi: 10.3109/07357907.2011.605412. Epub 2011 Aug 30. Cancer Invest. 2011. PMID: 21877938 Free PMC article.

2

Synergistic effect of celecoxib on TRAIL-induced apoptosis in hepatocellular carcinoma cells.

Lu G, Liu Y, Ji B, Wei F, Hao C, Wang G. Lu G, et al. Among authors: wei f. Cancer Invest. 2010 Jul;28(6):629-34. doi: 10.3109/07357900903095631. Cancer Invest. 2010. PMID: 20394499

3

Targeting A20 enhances TRAIL-induced apoptosis in hepatocellular carcinoma cells.

Dong B, Lv G, Wang Q, Wei F, Bellail AC, Hao C, Wang G. Dong B, et al. Among authors: wei f. Biochem Biophys Res Commun. 2012 Feb 10;418(2):433-8. doi: 10.1016/j.bbrc.2012.01.056. Epub 2012 Jan 20. Biochem Biophys Res Commun. 2012. PMID: 22285182

4

K-Ras mutation-mediated IGF-1-induced feedback ERK activation contributes to the rapalog resistance in pancreatic ductal adenocarcinomas.

Wei F, Liu Y, Bellail AC, Olson JJ, Sun SY, Lu G, Ding L, Yuan C, Wang G, Hao C. Wei F, et al. Cancer Lett. 2012 Sep 1;322(1):58-69. doi: 10.1016/j.canlet.2012.02.005. Epub 2012 Feb 14. Cancer Lett. 2012. PMID: 22342683 Free PMC article.

5

Simultaneous targeting of EGFR and mTOR inhibits the growth of colorectal carcinoma cells.

Li B, Gao S, Wei F, Bellail AC, Hao C, Liu T. Li B, et al. Among authors: wei f. Oncol Rep. 2012 Jul;28(1):15-20. doi: 10.3892/or.2012.1786. Epub 2012 Apr 26. Oncol Rep. 2012. PMID: 22552366

6

Combination of mTOR and EGFR kinase inhibitors blocks mTORC1 and mTORC2 kinase activity and suppresses the progression of colorectal carcinoma.

Wang Q, Wei F, Li C, Lv G, Wang G, Liu T, Bellail AC, Hao C. Wang Q, et al. Among authors: wei f. PLoS One. 2013 Aug 22;8(8):e73175. doi: 10.1371/journal.pone.0073175. eCollection 2013. PLoS One. 2013. PMID: 23991179 Free PMC article.

7

The association of TP53 mutations with the resistance of colorectal carcinoma to the insulin-like growth factor-1 receptor inhibitor picropodophyllin.

Wang Q, Wei F, Lv G, Li C, Liu T, Hadjipanayis CG, Zhang G, Hao C, Bellail AC. Wang Q, et al. Among authors: wei f. BMC Cancer. 2013 Nov 4;13:521. doi: 10.1186/1471-2407-13-521. BMC Cancer. 2013. PMID: 24182354 Free PMC article.

8

Exosomes derived from gemcitabine-resistant cells transfer malignant phenotypic traits via delivery of miRNA-222-3p.

Wei F, Ma C, Zhou T, Dong X, Luo Q, Geng L, Ding L, Zhang Y, Zhang L, Li N, Li Y, Liu Y. Wei F, et al. Mol Cancer. 2017 Jul 25;16(1):132. doi: 10.1186/s12943-017-0694-8. Mol Cancer. 2017. PMID: 28743280 Free PMC article.

9

[Mechanism underlying pancreatic cancer cell resistance to mTOR inhibitor RAD001 via c-Raf/ERK1/2 activation].

Wei F, Zhang P, Qi J, Wang M, Wang G. Wei F, et al. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2014 Jan;30(1):23-7. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2014. PMID: 24405594 Chinese.

10

mTOR inhibition induces EGFR feedback activation in association with its resistance to human pancreatic cancer.

Wei F, Zhang Y, Geng L, Zhang P, Wang G, Liu Y. Wei F, et al. Int J Mol Sci. 2015 Feb 3;16(2):3267-82. doi: 10.3390/ijms16023267. Int J Mol Sci. 2015. PMID: 25654224 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,979 results

Search Page

Filters